Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G

Journal of Virology

Volumn 83, Issue 2, 2009, Pages 884-895

  Trapp, Susanna ^a,c   Derby, Nina R ^a   Singer, Rachel ^a   Shaw, Andrew ^a   Williams, Vennansha G ^a   Turville, Stuart G ^a,d   Bess Jr , Julian W ^b   Lifson, Jeffrey D ^b   Robbiani, Melissa ^a  

^a POPULATION COUNCIL   (United States)

^b SAIC FREDERICK INC   (United States)

^c UNIVERSITY OF COLOGNE   (Germany)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; DOUBLE STRANDED RNA; INTERFERON; INTERLEUKIN 12; MONOMER; NEUTRALIZING ANTIBODY; POLYINOSINIC POLYCYTIDYLIC ACID; RECOMBINANT ALPHA INTERFERON; RECOMBINANT BETA INTERFERON; SMALL INTERFERING RNA;

ANTIVIRAL ACTIVITY; ARTICLE; DENDRITIC CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOSTIMULATION; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTION; VIRUS REPLICATION;

ANTI-HIV AGENTS; CELLS, CULTURED; CYTIDINE DEAMINASE; DENDRITIC CELLS; HIV-1; HUMANS; INTERFERONS; INTERLEUKIN-12; POLY I-C; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 58149502601     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00023-08     Document Type: Article

References (76)

1. Abudu, A., A. Takaori-Kondo, T. Izumi, K. Shirakawa, M. Kobayashi, A. Sasada, K. Fukunaga, and T. Uchiyama. 2006. Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms. Curr. Biol. 16:1565-1570.
2. Adalid-Peralta, L., V. Godot, C. Colin, R. Krzysiek, T. Tran, P. Poignard, A. Venet, A. Hosmalin, P. Lebon, C. Rouzioux, G. Chene, and D. Emilie. 2008. Stimulation of the primary anti-HIV antibody response by IFN-alpha in patients with acute HIV-1 infection. J. Leukoc. Biol. 83:1060-1067.
3. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124:783-801.
4. Ashkar, A. A., X. D. Yao, N. Gill, D. Sajic, A. J. Patrick, and K. L. Rosenthal. 2004. Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA. J. Infect. Dis. 190:1841-1849.
5. Bakri, Y., C. Schiffer, V. Zennou, P. Charneau, E. Kahn, A. Benjouad, J. C. Gluckman, and B. Canque. 2001. The maturation of dendritic cells results in postintegration inhibition of HIV-1 replication. J. Immunol. 166:3780-3788.
6. Black, P. L., K. M. McKinnon, S. L. Wooden, and M. A. Ussery. 1996. Antiviral activity of biological response modifiers in a murine model of AIDS. Requirement for augmentation of natural killer cell activity and synergy with oral AZT. Int. J. Immunopharmacol. 18:633-650.
7. Boullart, A. C., E. H. Aarntzen, P. Verdijk, J. F. Jacobs, D. H. Schuurhuis, D. Benitez-Ribas, G. Schreibelt, M. W. van de Rakt, N. M. Scharenborg, A. de Boer, M. Kramer, C. G. Figdor, C. J. Punt, G. J. Adema, and I. J. de Vries. 2008. Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E(2) results in high interleukin-12 production and cell migration. Cancer Immunol. Immunother. 57:1589-1597.
8. Brenchley, J. M., D. A. Price, and D. C. Douek. 2006. HIV disease: fallout from a mucosal catastrophe? Nat. Immunol. 7:235-239.
9. Canque, B., Y. Bakri, S. Camus, M. Yagello, A. Benjouad, and J. C. Gluckman. 1999. The susceptibility to X4 and R5 human immunodeficiency virus-1 strains of dendritic cells derived In vitro from CD34(+) hematopoietic progenitor cells is primarily determined by their maturation stage. Blood 93:3866-3875.
10. Carter, W. A., D. Ventura, D. E. Shapiro, D. R. Strayer, D. H. Gillespie, and H. R. Hubbell. 1991. Mismatched double-stranded RNA, Ampligen (poly(I): poly(C12U), demonstrates antiviral and immunostimulatory activities in HIV disease. Int. J. Immunopharmacol. 13(Suppl. 1):69-76.
11. Celum, C. L., N. J. Robinson, and M. S. Cohen. 2005. Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection. J. Infect. Dis. 191(Suppl. 1):S107-S114.
12. Chelico, L., P. Pham, P. Calabrese, and M. F. Goodman. 2006. APOBEC3G DNA deaminase acts processively 335 on single-stranded DNA. Nat. Struct. Mol. Biol. 13:392-399.
13. Chen, Y. H., W. Wu, J. Yang, S. F. Sui, J. Sun, and M. P. Dierich. 1999. Antibodies against human IFN-alpha and -beta recognized the immunosuppressive domain of HIV-1 gp41 and inhibit gp41-binding to the putative cellular receptor protein p45. Immunol. Lett. 69:253-257.
14. Chertova, E., J. W. Bess, Jr., B. J. Crise, I. R. Sowder, T. M. Schaden, J. M. Hilburn, J. A. Hoxie, R. E. Benveniste, J. D. Lifson, L. E. Henderson, and L. O. Arthur. 2002. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus. J. Virol. 76:5315-5325.
15. Chiu, Y. L., and W. C. Greene. 2008. The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu. Rev. Immunol. 26:317-353.
16. Chiu, Y. L., and W. C. Greene. 2006. APOBEC3 cytidine deaminases: distinct antiviral actions along the retroviral life cycle. J. Biol. Chem. 281:8309-8312.
17. Chiu, Y. L., V. B. Soros, J. F. Kreisberg, K. Stopak, W. Yonemoto, and W. C. Greene. 2005. Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature 435:108-114.
18. Derdeyn, C. A., J. M. Decker, J. N. Sfakianos, X. Wu, W. A. O'Brien, L. Ratner, J. C. Kappes, G. M. Shaw, and E. Hunter. 2000. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J. Virol. 74:8358-8367.
19. Douek, D. C., J. M. Brenchley, M. R. Betts, D. R. Ambrozak, B. J. Hill, Y. Okamoto, J. P. Casazza, J. Kuruppu, K. Kunstman, S. Wolinsky, Z. Grossman, M. Dybul, A. Oxenius, D. A. Price, M. Connors, and R. A. Koup. 2002. HIV preferentially infects HIV-specific CD4+ T cells. Nature 417:95-98.
20. Essey, R. J., B. R. McDougall, and W. E. Robinson, Jr. 2001. Mismatched double-stranded RNA (polyI-polyC(12)U) is synergistic with multiple anti-HIV drugs and is active against drug-sensitive and drug-resistant HIV-1 in vitro. Antivir. Res. 51:189-202.
21. Folks, T. M., D. Powell, M. Lightfoote, S. Koenig, A. S. Fauci, S. Benn, A. Rabson, D. Daugherty, H. E. Gendelman, M. D. Hoggan, et al. 1986. Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus. J. Exp. Med. 164:280-290.
22. Frank, I., M. J. Piatak, H. Stoessel, N. Romani, D. Bonnyay, J. D. Lifson, and M. Pope. 2002. Infectious and whole inactivated simian immunodeficiency viruses interact similarly with primate dendritic cells (DCs): differential intracellular fate of virions in mature and immature DCs. J. Virol. 76:2936-2951.
23. Frank, I., H. Stoessel, A. Gettie, S. G. Turville, J. W. Bess, Jr., J. D. Lifson, I. Sivin, N. Romani, and M. Robbiani. 2008. A fusion inhibitor prevents dendritic cell (DC) spread of immunodeficiency viruses but not DC activation of virus-specific T cells. J. Virol. 82:5329-5339.
24. Fricke, I., D. Mitchell, J. Mittelstadt, N. Lehan, H. Heine, T. Goldmann, A. Bohle, and S. Brandau. 2006. Mycobacteria induce IFN-gamma production in human dendritic cells via triggering of TLR2. J. Immunol. 176:5173-5182.
25. Frucht, D. M., T. Fukao, C. Bogdan, H. Schindler, J. J. O'Shea, and S. Koyasu. 2001. IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends Immunol. 22:556-560.
26. Fujimoto, C., Y. Nakagawa, K. Ohara, and H. Takahashi. 2004. Polyriboinosinic polyribocytidylic acid [poly(I:C)]/TLR3 signaling allows class I processing of exogenous protein and induction of HIV-specific CD8+ cytotoxic T lymphocytes. Int. Immunol. 16:55-63.
27. Fukao, T., S. Matsuda, and S. Koyasu. 2000. Synergistic effects of IL-4 and IL-18 on IL-12-dependent IFN-gamma production by dendritic cells. J. Immunol. 164:64-71.
28. Gill, N., P. M. Deacon, B. Lichty, K. L. Mossman, and A. A. Ashkar. 2006. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production. J. Virol. 80:9943-9950.
29. Granelli-Piperno, A., E. Delgado, V. Finkel, W. Paxton, and R. M. Steinman. 1998. Immature dendritic cells selectively replicate M-tropic HIV-1, while mature cells efficiently transmit both M- and T-tropic virus to T cells. J. Virol. 72:2733-2737.
30. Haase, A. T. 2005. Perils at mucosal front lines for HIV and SIV and their hosts. Nat. Rev. Immunol. 5:783-792.
31. Harman, A. N., J. Wilkinson, C. R. Bye, L. Bosnjak, J. L. Stern, M. Nicholle, J. Lai, and A. L. Cunningham. 2006. HIV induces maturation of monocyte-derived dendritic cells and Langerhans cells. J. Immunol. 177:7103-7113.
32. Heil, F., H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning, S. Akira, G. Lipford, H. Wagner, and S. Bauer. 2004. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303:1526-1529.
33. Herbst-Kralovetz, M. M., and R. B. Pyles. 2006. Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infection. J. Virol. 80:9988-9997.
34. Hertzog, P. J., L. A. O'Neill, and J. A. Hamilton. 2003. The interferon in TLR signaling: more than just antiviral. Trends Immunol. 24:534-539.
35. Ichinohe, T., I. Watanabe, S. Ito, H. Fujii, M. Moriyama, S. Tamura, H. Takahashi, H. Sawa, J. Chiba, T. Kurata, T. Sata, and H. Hasegawa. 2005. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection. J. Virol. 79:2910-2919.
36. Ignatius, R., M. Marovich, E. Mehlhop, L. Villamide, K. Mahnke, W. I. Cox, F. Isdell, S. Frankel, J. R. Mascola, R. M. Steinman, and M. Pope. 2000. Canarypox virus-induced maturation of dendritic cells is mediated by apoptotic cell death and tumor necrosis factor alpha secretion. J. Virol. 74:11329-11338.
37. Kariko, K., P. Bhuyan, J. Capodici, and D. Weissman. 2004. Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. J. Immunol. 172:6545-6549.
38. Kariko, K., and D. Weissman. 2007. Naturally occurring nucleoside modifications suppress the immunostimulatory activity of RNA: implication for therapeutic RNA development. Curr. Opin. Drug Discov. Dev. 10:523-532.
39. Kreisberg, J. F., W. Yonemoto, and W. C. Greene. 2006. Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation. J. Exp. Med. 203:865-870.
40. Matsumoto, M., and T. Seya. 2008. TLR3: interferon induction by double-stranded RNA including poly(I:C). Adv. Drug Deliv. Rev. 60:805-812.
41. Miller, C. J., Q. Li, K. Abel, E. Y. Kim, Z. M. Ma, S. Wietgrefe, L. La Franco-Scheuch, L. Compton, L. Duan, M. D. Shore, M. Zupancic, M. Busch, J. Carlis, S. Wolinksy, and A. T. Haase. 2005. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J. Virol. 79:9217-9227.
42. Mitchell, W. M., D. C. Montefiori, W. E. Robinson, Jr., D. R. Strayer, and W. A. Carter. 1987. Mismatched double-stranded RNA (ampligen) reduces concentration of zidovudine (azidothymidine) required for in-vitro inhibition of human immunodeficiency virus. Lancet i:890-892.
43. Morrow, G., L. Vachot, P. Vagenas, and M. Robbiani. 2007. Current concepts of HIV transmission. Curr. HIV/AIDS Rep. 4:29-35.
44. Neil, S. J., V. Sandrin, W. I. Sundquist, and P. D. Bieniasz. 2007. An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein. Cell Host Microbe 2:193-203.
45. Neil, S. J., T. Zang, and P. D. Bieniasz. 2008. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451:425-430.
46. Netea, M. G., C. Van Der Graaf, J. W. Van Der Meer, and B. J. Kullberg. 2004. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system. J. Leukoc. Biol. 75:749-755.
47. Peng, G., T. Greenwell-Wild, S. Nares, W. Jin, K. J. Lei, Z. G. Rangel, P. J. Munson, and S. M. Wahl. 2007. Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood 110:393-400.
48. Peng, G., K. J. Lei, W. Jin, T. Greenwell-Wild, and S. M. Wahl. 2006. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J. Exp. Med. 203:41-46.
49. Pion, M., A. Granelli-Piperno, B. Mangeat, R. Stalder, R. Correa, R. M. Steinman, and V. Piguet. 2006. APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection. J. Exp. Med. 203:2887-2893.
50. Pope, M., and A. T. Haase. 2003. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat. Med. 9:847-852.
51. Rose, K. M., M. Marin, S. L. Kozak, and D. Kabat. 2004. Transcriptional regulation of APOBEC3G, a cytidine deaminase that hypermutates human immunodeficiency virus. J. Biol. Chem. 279:41744-41749.
52. Salazar, A., J. Morales, et al. 1990. Intramuscular poly-ICLC in HIV infection: preliminary findings. Neurology 40:238.
53. Salazar, A. M., H. B. Levy, S. Ondra, M. Kende, B. Scherokman, D. Brown, H. Mena, N. Martin, K. Schwab, D. Donovan, D. Dougherty, M. Pulliam, M. Ippolito, M. Graves, H. Brown, and A. Ommaya.1996. Long-term treatment of malignant gliomas with intramuscularly administered polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethylcellulose: an open pilot study. Neurosurgery 38:1096-1103.
54. Samuel, C. E. 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14:778-809.
55. Sanders, R. W., E. C. de Jong, C. E. Baldwin, J. H. Schuitemaker, M. L. Kapsenberg, and B. Berkhout. 2002. Differential transmission of human immunodeficiency virus type 1 by distinct subsets of effector dendritic cells. J. Virol. 76:7812-7821.
56. Sanghavi, S. K., and T. A. Reinhart. 2005. Increased expression of TLR3 in lymph nodes during simian immunodeficiency virus infection: implications for inflammation and immunodeficiency. J. Immunol. 175:5314-5323.
57. Schlaepfer, E., A. Audige, H. Joller, and R. F. Speck. 2006. TLR7/8 triggering exerts opposing effects in acute versus latent HIV infection. J. Immunol. 176:2888-2895.
58. Sheehy, A. M., N. C. Gaddis, J. D. Choi, and M. H. Malim. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650.
59. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264.
60. Steinman, R. M., D. Hawiger, and M. C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:685-711.
61. Steinman, R. M., and H. Hemmi. 2006. Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 311:17-58.
62. Stopak, K. S., Y. L. Chiu, J. Kropp, R. M. Grant, and W. C. Greene. 2007. Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells. J. Biol. Chem. 282:3539-3546.
63. Svensson, A., L. Bellner, M. Magnusson, and K. Eriksson. 2007. Role of IFN-alpha/beta signaling in the prevention of genital herpes virus type 2 infection. J. Reprod. Immunol. 74:114-123.
64. Tanaka, Y., H. Marusawa, H. Seno, Y. Matsumoto, Y. Ueda, Y. Kodama, Y. Endo, J. Yamauchi, T. Matsumoto, A. Takaori-Kondo, I. Ikai, and T. Chiba. 2006. Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes. Biochem. Biophys. Res. Commun. 341:314-319.
65. Thielen, B. K., K. C. Klein, L. W. Walker, M. Rieck, J. H. Buckner, G. W. Tomblingson, and J. R. Lingappa. 2007. T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activity. PLoS Pathog. 3:1320-1334.
66. Tiscornia, G., O. Singer, and I. M. Verma. 2006. Production and purification of lentiviral vectors. Nat. Protoc. 1:241-245.
67. Trapp, S., S. G. Turville, and M. Robbiani. 2006. Slamming the door on unwanted guests: why preemptive strikes at the mucosa may be the best strategy against HIV. J. Leukoc. Biol. 80:1076-1083.
68. Trkola, A., A. B. Pomales, H. Yuan, B. Korber, P. J. Maddon, G. P. Allaway, H. Katinger, C. F. I. Barbas, D. R. Burton, D. D. Ho, and J. P. Moore. 1995. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-immunoglobulin G. J. Virol. 69:6609-6617.
69. Trumpfheller, C., M. Caskey, G. Nchinda, M. P. Longhi, O. Mizenina, Y. Huang, S. J. Schlesinger, M. Colonna, and R. M. Steinman. 2008. The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine. Proc. Natl. Acad. Sci. USA 105:2574-2579.
70. Turville, S. G., J. J. Santos, I. Frank, P. U. Cameron, J. Wilkinson, M. Miranda-Saksena, J. Dable, H. Stoessel, N. Romani, M. Piatak, J. D. Lifson, M. Pope, and A. L. Cunningham. 2004. Immunodeficiency virus uptake, turnover and two phase transfer in human dendritic cells. Blood 103:2170-2179.
71. Turville, S. G., K. Vermeire, J. Balzarini, and D. Schols. 2005. Sugar-binding proteins potently inhibit dendritic cell human immunodeficiency virus type 1 (HIV-1) infection and dendritic cell-directed HIV-1 transfer. J. Virol. 79:13519-13527.
72. Vachot, L., V. G. Williams, J. W. Bess, Jr., J. D. Lifson, and M. Robbiani. 2008. Candida albicans-induced DC activation partially restricts HIV amplification in DCs and increases DC-to-T-cell spread of HIV. J. Acquir. Immune Defic. Syndr. 48:398-407.
73. Wong, J. P., M. E. Christopher, A. M. Salazar, R. M. Dale, L. Q. Sun, and M. Wang. 2007. Nucleic acid-based antiviral drugs against seasonal and avian influenza viruses. Vaccine 25:3175-3178.
74. Wu, L., and V. N. KewalRamani. 2006. Dendritic-cell interactions with HIV: infection and viral dissemination. Nat. Rev. Immunol. 6:859-868.
75. Yu, T., Y. Xiao, Y. Bai, Q. Ru, G. Luo, M. P. Dierich, and Y. Chen. 2000. Human interferon-beta inhibits binding of HIV-1 gp41 to lymphocyte and monocyte cells and binds the potential receptor protein P50 for HIV-1 gp41. Immunol. Lett. 73:19-22.
76. Zhang, S. Y., E. Jouanguy, V. Sancho-Shimizu, H. von Bernuth, K. Yang, L. Abel, C. Picard, A. Puel, and J. L. Casanova. 2007. Human Toll-like receptor-dependent induction of interferons in protective immunity to viruses. Immunol. Rev. 220:225-236.